急性心肌梗死治疗中溶栓剂促凝血作用及抗凝治疗的研究进展
被引量:4
Progress in Procoagulant Effect of Thrombolytic and Anticoagulant Therapy in Acute Myocardial Infarction
摘要
国外学者从三方面对溶栓剂促凝血作用进行了研究 :1.确定了能较准确反映凝血活性的特异性分子标记物检测指标。2 .在探讨溶栓后凝血活性增强的机制方面 ,证实纤溶酶可在无带负电异物表面的血液中激活激肽释放酶 -因子 系统 ,进而导致凝血酶激活。 3 .为抗凝剂的使用提供了理论依据 。
出处
《心血管病学进展》
CAS
2002年第3期145-148,共4页
Advances in Cardiovascular Diseases
参考文献24
-
1[1]Jonathan S. Scharfstein,Dana R. Abendschein,et al. Usefulness of fib rinogenolytic and procoagulant markers during thrombolytic therapy in pre dicting clinical outcomes in acute myocardial infarction[J]. Am J Cardiol,1996,78:503-510.
-
2[2]1996 Update. ACC/AHA Guidelines for the management of patients with a cute myocardial infarction: executive summary and recommendations. A report of the American college of cardiology/American heart association task force on practice guidelines(Committee on management of acute myocardial infarction)
-
3[3]Piera Angelic Merlini PA,Marco Cattaneo M,et al. Activation of hemostatic system during thrombolytic therapy[J]. Am J Cardiol, 1 993,72: 59G- 65G.
-
4[4]Eisenberg PR,Sherman LA,Jaffe AD. Paradoxic elevation of fibrinopep tide A after streptokinase:evidence for continued thrombosis despite fibrinolysis[J]. J Am Coll Candiol,1987,10: 527-529.
-
5[5]Owen J,Friedman KD,Grossman BA,et al. Thrombolytic therapy with tis sue type plasminogen activator or streptokinase induced transient thrombin activity[J]. Blood, 1988,72 : 616-620.
-
6[6]Gulba DC,Barthels M,Westhoff-Bleck M,et al. Increased thrombin levels during thrombolytic therapy in acute myocardial infarction[J]. Circulation,1991,83:937-944.
-
7[7]Rapold HJ,de Bono D,Amold AERt et al. For the European Cooperative Study Plasma fibrinopeptide A levels in patients with myocardial infarction treated with alteplase[J]. Circulation, 1992, 85 : 928-934.
-
8[8]Eisenberg PR,Sobel BE,Jaffe AS. Activation of prothrombin accompanying thrombolyais with recombinant tissue-type plasminogen activator[J].J Am Coll Cardiol, 1992,19:1065-1069.
-
9[9]Ewald GA,Eisenberg PR. Plasmin-mediated activation of contact system in response to pharmacological thrombolysis[J]. Circulation, 1995,92 : 28-36.
-
10[10]Hoffimeister HM, Szabo S, et al. Thrombolytic therapy in acute myocardial infarction. Comparison of procoagulant effects of streptokinase and alteplase regimens with focus on the kallikrein system and plasmin[J]. Circulation, 1998,2527-2533.
同被引文献24
-
1杜天敏.急性心肌梗死溶栓成功后ST段再抬高10例分析[J].疑难病杂志,2002,1(3):132-132. 被引量:1
-
2景彩,姚道阔,高美常,吴同果.急性心肌梗死溶栓治疗后ST段再抬高的临床分析[J].临床心血管病杂志,2004,20(9):525-526. 被引量:6
-
3庞霞.急性心肌梗死溶栓治疗后ST段再抬高的临床意义[J].实用心电学杂志,2006,15(2):97-98. 被引量:2
-
4宋梅,姚成立,李溪,刘婧,姜清茹.急性心肌梗死静脉溶栓治疗后ST段再抬高的临床意义[J].宁夏医学杂志,2006,28(8):576-577. 被引量:1
-
5急性心肌梗塞溶栓疗法参考方案(1996年7月修订)[J].中华心血管病杂志,1996,24(5):328-329. 被引量:1321
-
6庄义浩 杨俊芬 李文广 等.急性心肌梗死溶栓治疗中ST段再抬高的意义[J].国外医学:心血管疾病分册,2000,28(5):284-285.
-
7Shecther M, Rabinowitz B, Beker B, et al. Additional ST segment elevation during the first hour of thrombolytic therapy: An electrocardiographic sign predicting a favorable clinical outcome [J]. J Am Coil Cardial, 1992; 20 (7): 1460-1464
-
8Kondo M, Tarnura K, Tanio H, et al. Is ST segment re-elevation associated with reperfusion an indicator marked myocardial damage after thrombolysis? [J] J Am Coll Cardial,1993;21:62-67
-
9Hemens WT, van der Veen FH, Willems GM. Complete in plasma of enzymes lost from the heart after pemanemt eotonary artery occluslon in the dog[J]. Circulation, 1990, 81:649-659.
-
10Schwerrdt H, Ozbek C, Frohieffer H, et al. Optimised ffunction for detemining time to peak creatine kinase and creatinr kinase-MB AS non - invasive reperfusion indicators after thrombilytic inacute myocardial infarction [ J ]. Cardovase Res, 1990, 24 : 328-334.
引证文献4
-
1郭任维,任艳琴,王春玲,邹阳春.急性心肌梗死溶栓治疗后迟发性ST段再抬高的临床意义[J].中国医药导刊,2008,10(9):1332-1333. 被引量:3
-
2余文辉,李冬虹,万新红.急性心肌梗死溶栓疗效与血清CK-MB的关系[J].中国煤炭工业医学杂志,2003,6(6):497-499.
-
3季梅,季华,季强,庞在英.小剂量尿激酶溶栓治疗老年急性心肌梗死临床观察[J].疑难病杂志,2003,2(3):152-153. 被引量:4
-
4刘林红,王冬梅,王诗哲,姜兴余,崔斌.急性心肌梗死静脉溶栓治疗后ST段再抬高临床意义探讨[J].中国综合临床,2003,19(7):658-659. 被引量:6
二级引证文献13
-
1梁显锋,张强.急诊溶栓治疗急性心肌梗死25例疗效分析[J].右江医学,2005,33(2):181-182. 被引量:2
-
2刘春来,刘锁民,刘屹立,王平.尿激酶治疗血液透析患者动静脉内瘘血栓形成的临床体会[J].疑难病杂志,2006,5(3):198-199. 被引量:8
-
3王杏儒,赵明哲,王菁.尿激酶静脉溶栓治疗急性脑梗死30例临床观察[J].疑难病杂志,2007,6(10):613-614. 被引量:1
-
4王虹,黄从新,林英忠,王风.静脉溶栓对急性心肌梗死治疗效果的多因素分析[J].中国老年学杂志,2007,27(22):2201-2203. 被引量:2
-
5郭任维,任艳琴,王春玲,邹阳春.急性心肌梗死溶栓治疗后迟发性ST段再抬高的临床意义[J].中国医药导刊,2008,10(9):1332-1333. 被引量:3
-
6潘永丽,吴宗劲.急性心肌梗死静脉溶栓治疗160例临床分析[J].中国医药导报,2009,6(23):21-22.
-
7王稻,陈清萍,田利娜,廖雯,曹珊.尿激酶局部溶栓治疗血液透析患者动静脉内瘘血栓形成[J].甘肃医药,2011,30(11):651-653. 被引量:4
-
8张宏伟,许虹,李元红,及心.女性急性心肌梗死静脉溶栓后ST段再抬高对预后的影响[J].中国循证心血管医学杂志,2012,4(2):136-138. 被引量:4
-
9刘瑞萍.静脉溶栓对急性心肌梗死治疗效果的多因素分析[J].中国医药指南,2013,11(13):140-141. 被引量:3
-
10邹艳惠.影响老年急性心肌梗死溶栓治疗的相关原因分析[J].中外医疗,2014,33(12):89-90. 被引量:2
-
1代谢病[J].国外科技资料目录(医药卫生),2002(7):96-97.
-
2崔广凯,黄平和,李晓东,马淑梅.陈旧性心梗患者Ptfv_1与心室晚电位之间关系的探讨[J].心血管康复医学杂志,1999,8(1):59-61.
-
3苏卓娃,杜冀晖,查文清,麦丽文,王晓燕.急性心肌梗死和心房纤维性颤动患者CD62P、CD63与vWF检测的意义[J].实用心脑肺血管病杂志,2004,12(6):323-325.
-
4吴长明,陈群,沈丽丽,徐尚志.血浆心型脂肪酸结合蛋白水平对急性冠脉综合征辅助诊断的临床意义[J].中国现代医生,2012,50(8):41-42. 被引量:5
-
5李坤刚,王艳霞,张连发.不典型症状急性心肌梗死48例分析[J].中国实用医药,2012,7(2):139-140. 被引量:2
-
6李刚,杨丽莉,武赟堂,付海燕,吴强,张瑞俊,张娟,李虎,吴庭艳.粪便生物标记物检测对溃疡性结肠炎的诊断价值研究[J].胃肠病学和肝病学杂志,2014,23(7):783-785. 被引量:7
-
7陈敦雁,阙厦丹.浅论对心肌损伤患者进行5种常见心肌损伤标记物检测的临床意义[J].当代医药论丛,2015,13(14):59-60.
-
8张文婷,吴小平.粪便标记物在炎症性肠病中的应用[J].胃肠病学,2011,16(9):558-561. 被引量:4
-
9汤净.血清HBV标记物检测在消化性溃疡中的意义[J].新消化病学杂志,1996,4(3):138-139. 被引量:5
-
10郑宇,董培红,金益辉,金小亚,陈永平.伤寒并发中毒性肝炎的肝功能分析[J].中国现代医学杂志,2003,13(2):41-42. 被引量:4